Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,677 | -12,309 | -6,556 | -20,849 | -15,992 |
| Depreciation Amortization | 2,841 | 1,882 | 933 | 2,895 | 2,379 |
| Accounts receivable | 317 | -1,729 | 36 | 417 | 558 |
| Accounts payable and accrued liabilities | 919 | -211 | -688 | 284 | 35 |
| Other Working Capital | 2,190 | -2,263 | -1,326 | 196 | 369 |
| Other Operating Activity | 491 | 1,834 | -13 | -333 | -814 |
| Operating Cash Flow | $-14,919 | $-12,796 | $-7,614 | $-17,390 | $-13,465 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,000 | 3,000 | 3,000 | 4,497 | 4,499 |
| PPE Investments | -656 | -346 | -220 | -339 | -105 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -6,283 | -6,283 |
| Other Investing Activity | 0 | 0 | 0 | -6,283 | -6,283 |
| Investing Cash Flow | $2,344 | $2,654 | $2,780 | $-2,125 | $-1,889 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 5,000 | 15,000 | 15,000 |
| Debt Repayment | -1,217 | -797 | -391 | -11,671 | -11,293 |
| Common Stock Issued | 95,123 | 13,801 | 13,051 | 17,350 | 9,906 |
| Other Financing Activity | -1,778 | -574 | 0 | 232 | 232 |
| Financing Cash Flow | $102,128 | $22,430 | $17,660 | $20,911 | $13,845 |
| Beginning Cash Position | 13,343 | 13,343 | 13,343 | 11,947 | 11,947 |
| End Cash Position | 102,896 | 25,631 | 26,169 | 13,343 | 10,438 |
| Net Cash Flow | $89,553 | $12,288 | $12,826 | $1,396 | $-1,509 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,919 | -12,796 | -7,614 | -17,390 | -13,465 |
| Capital Expenditure | -656 | -346 | -220 | -339 | -105 |
| Free Cash Flow | -15,575 | -13,142 | -7,834 | -17,729 | -13,570 |